Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy  | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Laura Machin Galarza | Pharmacology | Young Scientist Award

Published on by World Top Scientists

Assist. Prof. Dr. Laura Machin Galarza | Pharmacology | Young Scientist Award

Laura Machin Galarza | University of Havana | Cuba

Dr. Laura Machin Galarza is an Assistant Professor and Researcher at the Institute of Pharmacy and Foods, University of Havana, specializing in pharmaceutical sciences and parasitology. She holds a Bachelor’s, Master’s, and Doctorate in Pharmaceutical Sciences from the University of Havana, where her academic journey has been marked by excellence and commitment to translational research. Dr. Machin has undertaken prestigious research stays at institutions in Austria, Germany, China, and Cuba, contributing to international collaborations focused on pharmacology, toxicology, and biopharmaceutical innovation. Her professional experience includes leadership in multidisciplinary projects exploring the antiprotozoal and antileishmanial potential of natural and synthetic compounds, advanced drug delivery systems, and pharmacological recycling strategies. She has authored multiple peer-reviewed publications in high-impact journals such as Pharmaceuticals, Molecules, and Experimental Parasitology, demonstrating expertise in medicinal chemistry and drug development. Dr. Machin’s work has been recognized through contributions to award-winning research honored by the Cuban Academy of Sciences. She actively serves in academic editorial processes, participates in professional scientific societies, and holds certifications that reflect her dedication to research excellence, innovation, and scientific leadership in the field of pharmaceutical sciences.

Profiles: Google Scholar | Scopus 

Featured Publications

1. B. Salehi, L. Machin, L. Monzote, J. Sharifi-Rad, S. M. Ezzat, M. A. Salem, et al., “Therapeutic potential of quercetin: new insights and perspectives for human health,” ACS Omega, vol. 5, no. 20, pp. 11849–11872, 2020.

2. B. Tamargo, L. Monzote, A. Piñón, L. Machín, M. García, R. Scull, W. N. Setzer, “In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis,” Medicines, vol. 4, no. 2, p. 38, 2017.

3. L. Machín, R. Nápoles, L. Gille, L. Monzote, “Leishmania amazonensis response to artemisinin and derivatives,” Parasitology International, vol. 80, p. 102218, 2021.

4. G. Geroldinger, M. Tonner, J. Quirgst, M. Walter, S. De Sarkar, L. Machín, et al., “Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: a possible link,” Biochemical Pharmacology, vol. 173, p. 113737, 2020.

5. L. Machín, B. Tamargo, A. Piñón, R. C. Atíes, R. Scull, W. N. Setzer, L. Monzote, “Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) essential oils formulated in nanocochleates against Leishmania amazonensis,” Molecules, vol. 24, no. 23, p. 4222, 2019.

Lixin Yan | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Mrs. Lixin Yan | Pharmacology | Best Researcher Award

Medical manager | Sinocelltech Ltd | China

Mrs. Lixin Yan is an accomplished medical manager with extensive experience in clinical research, specializing in oncology, infectious diseases, vaccines, and metabolic products. Over the years, she has led multiple Phase I–III clinical trials, contributing to protocol development, medical monitoring, feasibility assessment, and regulatory submissions. Her work has been instrumental in the clinical development of innovative therapies, including PD-1 inhibitors, EGFR-targeted treatments, HPV and COVID-19 vaccines, insulin, and GLP-1 products. She demonstrates strong expertise in GCP compliance, regulatory processes, and cross-functional team collaboration, ensuring high-quality research outcomes. Mrs. Yan has published impactful peer-reviewed articles, including first-author papers, highlighting her ability to generate reliable clinical evidence. Her dedication to advancing medical science through rigorous research and mentorship reflects her potential to lead future high-impact studies. Her measurable research impact is demonstrated through 68 citations, 5 documents, and an h-index of 4 according to Scopus.

Profile: Scopus

Featured Publications

1. L. Yan, J. Yi, D. Liu, J. Li, A. A. H. Baidoo, and L. Xie, “Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial,” Contemporary Clinical Trials Communications, 2025.

Ksenia Blinova | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Prof. Dr. Lichun Zhao is a distinguished researcher and academic leader specializing in trace elements, traditional medicine, and health development. He serves as a doctoral supervisor, director of research centers and laboratories, and executive editor in chief of Trace Elements and Health Research, while holding key leadership roles in national and regional scientific associations. Recognized with numerous prestigious honors, he has successfully led major national and international projects, secured innovative medicine approvals, and contributed to product development. His prolific output includes over two hundred publications, highly cited SCI papers, multiple monographs, patents, and software copyrights, reflecting both scientific innovation and practical application. He has also been honored with multiple science and technology awards, underscoring the impact of his research. Committed to advancing both scholarship and healthcare, Prof. Zhao exemplifies excellence in integrating academic research, innovation, and leadership, making him a highly influential figure in his field.

Professional Profile 

Scopus Profile

Education

Prof. Dr. Lichun Zhao earned his Ph.D. in a field closely related to trace elements, medicine, and health sciences, building a solid academic foundation for his future research. Following his doctoral studies, he pursued postdoctoral training at Hong Kong Baptist University, where he broadened his expertise and gained valuable international research exposure. His educational journey reflects a strong emphasis on both traditional medicine and modern scientific approaches, allowing him to bridge classical knowledge with contemporary methodologies. By combining advanced laboratory techniques with deep understanding of traditional Chinese medicine, he has cultivated a unique academic profile that continues to drive his research innovations. His educational background not only prepared him for his roles in academia and research but also established his credentials as a mentor for doctoral students and an authoritative voice in integrating traditional practices with modern scientific frameworks.

Experience

Prof. Dr. Zhao has accumulated extensive academic and professional experience through his multiple leadership roles and active engagement in research. He serves as a doctoral supervisor, guiding and mentoring the next generation of researchers, while simultaneously holding positions as director of the Research Department and the Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Beyond his university roles, he directs major laboratories in Guizhou and Guangxi, leading innovation in endangered medicinal resources. His editorial work as executive editor in chief of Trace Elements and Health Research further demonstrates his commitment to advancing scholarly communication. In addition, he actively contributes to national scientific development as a project evaluation expert for significant research foundations and technology awards. Through these experiences, Prof. Zhao has built a career that integrates research, leadership, and service, positioning him as both a pioneering scientist and an influential academic administrator.

Research Focus

The core of Prof. Dr. Zhao’s research lies in the intersection of trace elements, traditional Chinese medicine, and health development. His work emphasizes the exploration of medicinal resources, the development of innovative treatments, and the application of modern scientific tools such as big data and artificial intelligence to healthcare research. He has led numerous national and international projects aimed at advancing understanding of trace elements in human health, as well as developing standardized, evidence-based approaches to traditional medicine. A significant part of his focus is dedicated to the preservation and innovation of endangered medicinal materials, ensuring sustainable resources for future therapeutic use. His achievements include obtaining clinical approvals for new medicine, producing certified products, and publishing influential studies recognized globally. Prof. Zhao’s research is notable for its ability to combine ancient knowledge with modern technology, creating novel solutions that enhance healthcare outcomes and scientific advancement.

Award and Honor

Prof. Dr. Zhao has been widely recognized for his scientific excellence and leadership with numerous national and regional awards. He was the first to receive the prestigious National Youth Qihuang Scholar distinction and has been selected for Hong Kong’s “Excellent Talent Plan.” His honors include recognition as an Outstanding Scholar in Guangxi, a leader of high-level innovation teams, and a candidate in talent development initiatives such as the “Ten Hundred Thousand Talents Project.” He has also received the Guangxi Youth Science and Technology Award and multiple provincial science and technology prizes, including the Guangxi Science and Technology Progress Award and the Jilin Province Natural Science Award. His contributions have further been acknowledged through the China Industry-University-Research Cooperation Innovation Award. Collectively, these distinctions highlight not only his research excellence but also his role as an innovator and leader whose work has had profound impact in both academic and applied scientific fields.

Publications Top Notes

  • Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Bacteriostatic activity and mechanism of minerals containing rubidium
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 3

  • Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 13

  • Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Authors: Zhao Lichun et al.
    Year: 2024
    Citations: 22

Conclusion

The reviewed publications of Prof. Dr. Lichun Zhao reflect a strong and diverse research portfolio spanning trace elements, traditional Chinese medicine, cancer biology, inflammatory diseases, and innovative material science applications. His works demonstrate both depth in exploring mechanisms of disease and breadth in applying interdisciplinary approaches to health solutions. The range of topics covered—from Alzheimer’s disease and rhinosinusitis to breast cancer and ulcerative colitis—highlights his ability to integrate traditional medicine knowledge with modern biomedical and technological advances. The citations already received for some of these recent studies, particularly in high-impact areas such as cancer research and therapeutic innovations, indicate growing recognition of his contributions within the scientific community. Overall, his research achievements showcase academic rigor, innovation, and practical significance, further strengthening his candidacy for recognition through prestigious research awards.

Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Assist. Prof. Dr. Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Petra University, Jordan

Dr. Dania Alhyari is an accomplished pharmaceutical sciences researcher and assistant professor with over a decade of experience in academia, research, and mentorship. Her expertise lies in drug formulation, permeability, solubility, and phytochemistry, with a strong focus on enhancing drug bioavailability and therapeutic efficacy. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, and a Master’s in Molecular Biology from the University of Ottawa, Canada. Throughout her career, she has been actively involved in teaching and research, currently serving as an Assistant Professor at Petra University, Jordan, where she mentors graduate students and leads research projects on novel drug delivery systems. Previously, she was a Postdoctoral Fellow at the University of Bradford, where she collaborated on interdisciplinary research and presented findings at international conferences. Dr. Alhyari has published extensively in reputed journals, contributing to advancements in pharmaceutical sciences. Her work emphasizes the integration of molecular biology with drug formulation to optimize therapeutic outcomes. She has also received recognition for her academic contributions, including invitations to speak at conferences and research grants for her studies. With a strong background in teaching, research, and international collaboration, Dr. Alhyari continues to make significant contributions to pharmaceutical innovation.

Professional Profile

Education

Dr. Dania Alhyari holds a strong academic background in pharmaceutical sciences and molecular biology, which has shaped her expertise in drug formulation and biopharmaceutical research. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, where she focused on drug permeability and solubility studies, developing innovative methodologies to enhance drug bioavailability. Her doctoral research involved interdisciplinary collaborations and was presented at several international conferences. Prior to her Ph.D., she completed a Master’s degree in Molecular Biology at the University of Ottawa, Canada, where she gained in-depth knowledge of biochemical and genetic interactions related to pharmaceutical applications. During her master’s studies, she engaged in extensive laboratory work, investigating drug interactions at the molecular level. Her academic journey began with a Bachelor’s degree in Pharmacy, where she developed a solid foundation in drug formulation, pharmacokinetics, and analytical techniques. Throughout her education, Dr. Alhyari actively participated in research projects, contributing to publications and advancing pharmaceutical knowledge. Her diverse educational background, spanning pharmacy, molecular biology, and pharmaceutical sciences, has provided her with a multidisciplinary perspective that enhances her research capabilities. With a commitment to scientific discovery, her education has been instrumental in shaping her career in academia and pharmaceutical research.

Professional Experience

Dr. Dania Alhyari has amassed extensive professional experience in pharmaceutical research and academia, contributing significantly to drug formulation, solubility, and permeability studies. She currently serves as an Assistant Professor at Petra University, Jordan, where she teaches advanced courses in pharmaceutics and pharmaceutical technology while mentoring graduate students in innovative drug delivery research. In this role, she leads research projects exploring novel drug formulations and collaborates with international experts to enhance pharmaceutical applications. Prior to this, she worked as a Postdoctoral Fellow at the University of Bradford, UK, where she developed cutting-edge methodologies for drug permeability and solubility studies. During her postdoctoral tenure, she mentored students, presented her findings at international conferences, and worked closely with interdisciplinary teams to advance pharmaceutical research. Earlier in her career, Dr. Alhyari served as a Research and Teaching Assistant at Petra University, where she played a key role in curriculum development, laboratory research, and student mentorship. She co-authored multiple research papers and contributed to the design of laboratory experiments that enhanced the university’s pharmaceutical research capabilities. Her professional journey reflects a strong balance between research, teaching, and leadership, positioning her as a key contributor to the advancement of pharmaceutical sciences and education.

Research interest

Dr. Dania Alhyari’s research interests lie at the intersection of drug formulation, permeability, solubility, and phytochemistry, with a focus on optimizing drug delivery systems for improved therapeutic outcomes. She is particularly interested in enhancing the bioavailability of pharmaceutical compounds by studying their physicochemical and biopharmaceutical properties. Her work explores innovative drug delivery mechanisms, including novel excipients, nanoformulations, and targeted drug transport to improve drug absorption and efficacy. Additionally, she investigates the role of natural compounds in pharmaceutical sciences, studying their antioxidant, anti-inflammatory, and bioavailability-enhancing properties. Through interdisciplinary collaborations, she integrates molecular biology techniques with pharmaceutical sciences to better understand drug interactions at the cellular and molecular levels. Dr. Alhyari is also passionate about the development of more efficient and patient-friendly pharmaceutical formulations, ensuring safer and more effective therapeutic interventions. Her research extends to the evaluation of drug-excipient interactions, solubility enhancement strategies, and the design of pharmaceutical formulations that cater to specific medical needs. By combining experimental research with advanced analytical techniques, she aims to contribute to the evolution of drug development and pharmaceutical innovation. Her research efforts have been recognized through publications in high-impact journals and presentations at international conferences.

Award & Honor

Dr. Dania Alhyari has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, research, and education. Her dedication to advancing drug formulation and delivery systems has earned her invitations to present her findings at prestigious international conferences, where she has been acknowledged for her innovative research. She has also secured research grants that have supported her studies in drug permeability, solubility enhancement, and pharmaceutical applications, further demonstrating the significance of her work. Throughout her academic career, she has been recognized for excellence in teaching and mentorship, guiding both undergraduate and graduate students in pharmaceutical research. Her contributions to scientific literature, including publications in high-impact journals, have been widely cited, highlighting the relevance of her research in the global pharmaceutical community. Additionally, she has collaborated with leading researchers from renowned institutions in the UK and Canada, receiving commendations for her interdisciplinary work in pharmaceutical sciences and molecular biology. Dr. Alhyari’s commitment to research excellence, innovation, and education continues to be acknowledged through various accolades, reinforcing her position as a leading researcher in her field. Her achievements reflect her dedication to pushing the boundaries of pharmaceutical research and inspiring future scientists.

Conclusion

Dania Alhyari is a strong candidate for the Best Researcher Award due to her research output, international collaborations, and academic contributions. However, strengthening aspects like grant funding, patents, and research impact metrics would further solidify her case.

Publications Top Notes

  • Physicochemical and biopharmaceutical characterization of new sulfonamide derivatives of gallic acid

    • Author(s): D. Alhyari, H. Sheldrake, S. Kantamneni, M. Isreb, S.J. Soumehsaraei, et al.

    • Year: 2022

    • Citations: 4

  • Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid

    • Author(s): D. Alhyari, N.A. Qinna, H.M. Sheldrake, S. Kantamneni, B.Y. Ghanem, et al.

    • Year: 2025

    • Citations: Not available yet (recent publication)

  • Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid

    • Author(s): D.H. Alhyari

    • Year: 2022

    • Citations: Not available (Thesis/Dissertation)

 

Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

full professor at Pázmány Péter Catholic University, Hungary

Franciska Vidáné Dr. Erdő is a distinguished researcher and professor in drug research and development, with extensive experience in academia and the pharmaceutical industry. Born on May 28, 1964, in Budapest, Hungary, she has contributed significantly to pharmacology, drug delivery, and biomedical research. Over her career, she has held leadership roles in prestigious institutions across Hungary, Germany, and France. As a full professor and lab head at Pázmány Péter Catholic University, she plays a key role in advancing scientific knowledge. Her research has been widely recognized, earning her multiple fellowships and memberships in international scientific societies. Dr. Erdő has supervised numerous students, organized international scientific meetings, and served as a reviewer for high-impact journals. She is also actively involved in grant evaluation for major research funding agencies in Europe, further establishing her as a leading expert in her field.

Professional Profile

Education

Dr. Erdő’s academic journey is rooted in pharmaceutical sciences. She obtained her MSc in Pharmacy from Semmelweis University, Faculty of Pharmacy, in 1987 with excellent distinction. She continued her studies at the same institution, earning her University Doctor title in pharmacology in 1994, followed by a PhD in 1997, both summa cum laude. To further enhance her expertise, she pursued a habilitation at Pázmány Péter Catholic University in 2019, ultimately achieving the title of full professor in 2024. Additionally, she has undertaken specialized training, including EU grant writing and experimental animal research under new EU regulations. Her diverse educational background has enabled her to excel in drug development, pharmacology, and biotechnology, equipping her with a strong foundation to lead innovative research in these fields.

Professional Experience

Dr. Erdő’s professional career spans more than three decades, encompassing roles in academia, research institutes, and the pharmaceutical industry. She has held various research fellow and senior research fellow positions in leading institutions such as Sanofi-Synthelabo Chinoin, IVAX Drug Research Institute, and SOLVO Biotechnology. Between 2000 and 2003, she was a Max Planck Fellow at the Max-Planck Institute in Germany, furthering her expertise in neurological research. She has also worked as a scientific researcher at Charité Medical University in Berlin. Since 2014, she has been an integral part of Pázmány Péter Catholic University, where she has progressed from senior research fellow to full professor and lab head. Her leadership in drug research and development, coupled with her extensive collaborations with international institutions, has significantly contributed to the advancement of pharmaceutical sciences.

Research Interests

Dr. Erdő’s research focuses on drug delivery across physiological barriers, including the skin, blood-brain barrier, and mucosal tissues. Her studies explore transdermal and intranasal drug administration, pharmacokinetics, and tissue engineering. She has contributed to the development of lab-on-a-chip models for drug testing, providing innovative solutions for pharmaceutical research. Her interdisciplinary approach combines pharmacology, biomedical engineering, and nanotechnology to improve drug formulation and delivery methods. She has authored numerous high-impact publications on skin permeability, microfluidic diffusion chambers, and age-related changes in drug absorption. Her research also includes in vitro and ex vivo studies on skin-on-a-chip platforms, contributing to advancements in personalized medicine. Dr. Erdő’s work has gained international recognition, shaping the future of drug development and targeted therapy solutions.

Awards and Honors

Dr. Erdő has been the recipient of numerous prestigious awards and fellowships throughout her career. She was a Max Planck Fellow from 2000 to 2003, a Charité Medical University Scholar in 2006, and a recipient of the LE STUDIUM Fellowship in 2022 under the Smart Loire Valley program in France. Her excellence in teaching and research has been recognized through multiple Teaching-Research Excellence Scholarships at Pázmány Péter Catholic University. She has also received publication fellowships for her outstanding contributions to scientific literature. Additionally, she plays a crucial role as a grant evaluator for the EU’s Horizon programs, the Austrian Science Fund, and other major research funding agencies. Her achievements highlight her significant impact on the global scientific community, reinforcing her reputation as a leading expert in pharmaceutical and biomedical research.

Conclusion

Dr. Franciska Vidáné Erdő is a highly suitable candidate for the Best Researcher Award due to her outstanding contributions to drug research, mentorship, and international collaborations. Her extensive publication record, leadership in scientific organizations, and impact on pharmacology and biomedical sciences make her a strong contender. Enhancing industry engagement and public science communication could further solidify her position as a top researcher.

Publications Top Noted

1. In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering

  • Author: Erdő F., et al.
  • Year: 2025
  • Journal: Bioengineering
  • DOI: 10.3390/bioengineering12030230

2. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

3. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

4. Mathematical Modeling of Transdermal Delivery of Topical Drug Formulations in a Dynamic Microfluidic Diffusion Chamber in Health and Disease

5. Rodent Models of Dermatological Disorders

6. Models for Barrier Understanding in Health and Disease in Lab-on-a-Chips

7. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

8. Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing

9. Editorial: Women in Drug Metabolism and Transport: 2021

10. Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers

11. Novel Aspects of Raman Spectroscopy in Skin Research

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Experimental Dermatology
  • DOI: 10.1111/exd.14645

12. Characterization and Ex Vivo Evaluation of Excised Skin Samples as Substitutes for Human Dermal Barrier in Pharmaceutical and Dermatological Studies

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Skin Research and Technology
  • DOI: 10.1111/srt.13165

13. Drug Delivery through the Psoriatic Epidermal Barrier—A “Skin-On-A-Chip” Permeability Study and Ex Vivo Optical Imaging

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms23084237

14. Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

15. Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents

 

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at University of Asia Pacific, Bangladesh

Dr. Shihab Uddin Ahmad (RPh, PhD) is an accomplished academic and researcher specializing in pharmacology, drug discovery, and molecular biology. Currently serving as an Assistant Professor and Coordinator of the Master of Pharmacy in Clinical Pharmacy and Pharmacology Program at the University of Asia Pacific, Bangladesh, he has made significant contributions to natural product pharmacology and functional medicine. With a postdoctoral background from Shanghai Jiao Tong University, he has actively engaged in cutting-edge research, particularly in stem cell therapy, metabolic diseases, and pharmaceutical innovations. His expertise spans experimental pharmacology, biotechnology, and advanced drug delivery systems, with a strong emphasis on translational research. A prolific author and patent holder, Dr. Ahmad’s work has been recognized through numerous publications in high-impact journals. His dedication to academic excellence and research innovation positions him as a leader in the field of pharmaceutical sciences.

Professional Profile

Education

Dr. Ahmad holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Universiti Kebangsaan Malaysia, where he focused on wound healing properties of medicinal plants. He earned his Master of Science in Pharmaceutical Technology (M. Pharm. Tech.) and Bachelor of Pharmacy (B. Pharm.) from the University of Asia Pacific, Bangladesh, demonstrating an early interest in drug formulation, bioactive compounds, and molecular pharmacology. His academic journey has been driven by a passion for pharmacological research and drug discovery, equipping him with extensive biomedical expertise. Through his education, he developed proficiency in biochemical and molecular techniques, tissue recombination assays, and computational drug analysis. His multidisciplinary training in pharmacology, biotechnology, and clinical pharmacy has enabled him to bridge the gap between traditional medicine and modern pharmaceutical innovations, fostering impactful research in phytomedicine and metabolic disorders.

Professional Experience

Dr. Ahmad has a diverse professional background, spanning academia, industry, and postdoctoral research. Currently, he serves as the Coordinator and Assistant Professor at the University of Asia Pacific, Bangladesh, where he oversees research and academic programs in clinical pharmacy and pharmacology. Previously, he was a Postdoctoral Fellow at Renji Hospital, Shanghai Jiao Tong University, China, where he worked on cancer research and stem cell-based therapies. His industry experience includes serving as a Scientific Program Coordinator and Senior Executive at Ibn-Sina Natural Medicine Division, focusing on herbal drug development and product management. Additionally, he worked in the pharmaceutical production sector, gaining hands-on expertise in drug formulation, quality control, and regulatory affairs. His combined experience in research, industry, and education makes him a well-rounded professional with a strong impact in the field of drug discovery and molecular pharmacology.

Research Interests

Dr. Ahmad’s research interests focus on natural product pharmacology, drug delivery technology, and molecular biology, particularly in the development of phytomedicines and nutraceuticals. His work explores metabolic disorders, including obesity, diabetes, fatty liver disease, and postmenopausal hormonal imbalances such as PCOS and osteoporosis. He has also contributed to cancer pharmacology, investigating novel anticancer compounds and nanoparticle-based drug delivery systems. His expertise extends to neurodegenerative diseases and tissue regeneration, utilizing CRISPR technology, stem cell research, and bioinformatics to advance therapeutic innovations. By integrating experimental pharmacology with computational analysis, he aims to bridge the gap between traditional medicine and modern drug development. His ongoing research projects involve nanomedicine, polymeric drug delivery, and personalized medicine, reflecting a multidisciplinary approach to pharmaceutical sciences.

Awards and Honors

Dr. Ahmad has received numerous awards and recognitions for his contributions to pharmaceutical sciences and biomedical research. He is a patent holder for an innovative wound healing medicament, showcasing his ability to translate research into real-world applications. His research projects have been supported by prestigious grants from institutions such as UAP, Dhaka University, and international funding agencies. He has been an invited speaker at scientific conferences and has received accolades for his publications in high-impact journals. His work in drug discovery and therapeutic innovations has positioned him as a leading researcher in phytomedicine and clinical pharmacology. With an impressive track record of scientific achievements, mentorship, and academic leadership, Dr. Ahmad continues to make significant contributions to the advancement of pharmaceutical and biomedical sciences.

Conclusion

Dr. Shihab Uddin Ahmad is a strong candidate for the Best Researcher Award due to his extensive research contributions, leadership, and innovation in pharmacology and drug discovery. His combination of academic excellence, technical expertise, and mentorship makes him well-deserving of recognition. While enhancing international collaboration and increasing high-impact publications would further strengthen his profile, his overall achievements position him as a highly competitive contender for the award.

Publications Top Noted

  • Network Pharmacology, Molecular Docking and Experimental Validation on Potential Application of Diabetic Wound Healing of Cinnamomum zeylanicum Through Matrix Metalloproteinases-8 And 9 (MMP-8 And MMP-9)

    • Authors: Akter, S., Ahmad, S., Bhuiyan, M., Dewan, I., Reza, R., Morshed, N., Samdani, M., Reza, M., Kumer, A., Mohamed, I. N.
    • Year: 2025
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/DDDT.S489113

  • Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design

    • Authors: Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M., Rahman, F. I., Mohamed, I. N., Reza, M. S.
    • Year: 2023
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/dddt.s432790

  • Antidiabetic Effect of Actinodaphne angustifolia and Profiling of Bioactive Metabolites using UPLC-QToF/ESI-MS Method

  • Improvement of lipid profile and hepatic oxidative stress in high-fat-diet-induced hyperlipidemic Swiss albino rats by Piper betle juice: evidences from in vivo and in silico studies

    • Authors: Jing, X., Sarker, M. R., Gifari, A. J., Maruf, R. A., Alam, S., Khan, F., Soma, M. A., Hossain, S., Ming, L. C., Ahmad, S. U.
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.1

  • A Dose Optimization Study of Marantodes pumilum (Blume) Kuntze Extracts for Wound Healing Effect in Animal Model

  • Evaluation of Wound-Healing and Antioxidant Effects of Marantodes pumilum (Blume) Kuntze in an Excision Wound Model

  • The Pharmacological Potential of Oil Palm Phenolics (OPP) Individual Components

    • Author: Ahmad, S. U.
    • Year: 2019
    • Journal: International Journal of Medical Sciences
    • DOI: 10.7150/ijms.29934

  • Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction

  • Antioxidant and Anti-inflammatory Activities of Marantodes pumilum (Blume) Kuntze and Their Relationship with the Phytochemical Content

  • Labisia pumila improves wound healing process in ovariectomized rat model

  • Phyto-estrogenic effects of Marantodes pumilum (Blume) kuntze syn. Labisia pumila (Blume) Fern.-Vill. for the prevention and treatment of post-menopausal diseases

    • Authors: Ahmad, S. U., Azam, A., Shuid, A. N., Mohamed, I. N.
    • Year: 2017
    • Journal: Indian Journal of Traditional Knowledge
    • EID: 2-s2.0-85011866753

 

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Dr. Anca-Roxana Petrovici, “Petru Poni” Institute of Macromolecular Chemistry, Romania

Dr. Anca-Roxana Petrovici is a prominent researcher at the “Petru Poni” Institute of Macromolecular Chemistry in Romania. With a strong focus on macromolecular science, she has made significant contributions to the field through her innovative research and publications, aiming to advance knowledge and applications in polymer chemistry.

Profile

Scopus

Orcid

Education 🎓

Dr. Petrovici obtained her Ph.D. in Macromolecular Chemistry, where her thesis focused on the synthesis and characterization of novel polymer materials. Her academic journey has been marked by a commitment to excellence and a passion for advancing the field of polymer science.

Experience 💼

With extensive experience at the “Petru Poni” Institute, Dr. Petrovici has engaged in various research projects and collaborations, contributing to the development of new materials and applications. Her role has also involved mentoring students and collaborating with industry partners to apply scientific findings practically.

Research Interest 🔬

Dr. Petrovici’s research interests lie primarily in the synthesis, characterization, and application of macromolecular materials. She focuses on the development of innovative polymers with specific functionalities, exploring their potential in diverse fields such as biomedicine, packaging, and nanotechnology.

Awards 🏆

Throughout her career, Dr. Petrovici has received numerous accolades recognizing her contributions to polymer chemistry. While specific awards are not listed here, her work has been widely cited, reflecting her influence in the scientific community.

Publication Top notes 📚

Correction: Simionescu et al. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021, 13, 988

Phenolic Composition and Bioactivities of Invasive Ailanthus altissima (Mill.) Swingle Leaf Extracts Obtained by Two-Step Sequential Extraction

In Vitro Screening of Ecotoxic and Cytotoxic Activities of Ailanthus altissima Leaf Extract against Target and Non-Target Plant and Animal Cells

Enhancing the Antioxidant Potential of Weissella confusa PP29 Probiotic Media through Incorporation of Hibiscus sabdariffa L. Anthocyanin Extract

Complexes of Ibuprofen Thiazolidin-4-One Derivatives with β-Cyclodextrin: Characterization and In Vivo Release Profile and Biological Evaluation

NEW METAL COMPLEXES WITH ARIL-ACETIC STRUCTURE: PREPARATION, CHARACTERIZATION, AND IN VITRO ANTIINFLAMMATORY EFFECTS

Dextran-Chitosan Composites: Antioxidant and Anti-Inflammatory Properties

3D Matrices for Enhanced Encapsulation and Controlled Release of Anti-Inflammatory Bioactive Compounds in Wound Healing

Dextran Formulations as Effective Delivery Systems of Therapeutic Agents

Probiotic Properties of Weissella confusa PP29 on Hibiscus sabdariffa L. Media

Radha Goel | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Prof Dr. Radha Goel | Pharmacology | Best Researcher Award

Professor, Lloyd Institute of Management & Technology, India

Dr. Radha Goel is a distinguished Professor and Animal House In-charge at Lloyd Institute of Management and Technology, Greater Noida. With a profound expertise in pharmacology and clinical research, she has dedicated her career to advancing pharmaceutical science through both teaching and research. Dr. Goel has been recognized for her exceptional contributions to education and research, including being honored with the Best Teacher Excellence Award by Dr. A.P.J. Abdul Kalam University, Lucknow.

Profile

Scopus

Strengths for the Award

Extensive Experience and Qualifications: Dr. Radha Goel has a robust academic background with advanced degrees in Pharmacology and Clinical Research. Her extensive experience spans various academic and research roles, including professorships at reputed institutions and work in clinical research.

Significant Research Contributions: Dr. Goel has made substantial contributions to the field of Pharmacology with numerous patents and publications. Her research spans several critical areas, including neuropathic pain, diabetes management, and novel drug formulations, showcasing her innovative approach.

Awards and Recognition: Dr. Goel has received notable accolades, such as the Best Teacher Excellence Award, highlighting her exceptional teaching and research achievements.

Strong Patent Portfolio: She holds several patents, including international ones, demonstrating her innovative impact on pharmaceutical and medical fields.

Prolific Publication Record: Dr. Goel has published extensively in high-impact journals and authored several books. Her work on neuropathic pain and diabetes management reflects significant advancements in these areas.

Areas for Improvement

Research Impact Metrics: While Dr. Goel has an impressive list of publications and patents, the impact of some of her research could be enhanced by focusing on higher-impact journals and integrating her work into broader interdisciplinary research networks.

Funding and Grants: Although she has received a travel grant, there is limited information on her success in securing larger research grants. Greater emphasis on acquiring and managing substantial research funding could further bolster her research profile.

Collaborative Research: Expanding collaborative efforts with international research groups could enhance the scope and impact of her research. This could also lead to more diverse and high-impact publications.

Innovation in Research Areas: While her research is extensive, there is room to explore emerging areas in pharmacology and clinical research to stay at the forefront of advancements and address new challenges in the field.

Education 🎓

Dr. Goel completed her Post Graduate Diploma in Clinical Research from IGMPI, Gurgaon (2016) and holds a Doctorate in Pharmacology from Jaipur National University (2012). She earned her Master in Pharmacology and Bachelor of Pharmacy from Hamdard University, New Delhi, in 2005 and 2002, respectively. Her foundational education includes higher secondary education from D.A.V Public School and Vidya Mandir Sr. Sec. School, Faridabad.

Experience 🏢

Dr. Goel has extensive academic experience, currently serving as a Professor at Lloyd Institute of Management and Technology since November 2023. She has previously held positions as Professor, Associate Professor, and Assistant Professor at Institute of Technology and Science (I.T.S.), Muradnagar, Ghaziabad. Her career also includes roles as a Lecturer at KIET College of Pharmacy and Clinical Research Associate at Jagsonpal Pharmaceuticals Ltd. Additionally, Dr. Goel has a significant research background from her M.Pharm experience.

Research Interest 🔬

Dr. Goel’s research interests focus on pharmacology, clinical research, and the development of novel therapeutic formulations. Her work includes nanoencapsulation techniques, drug delivery systems, and the study of plant-based treatments for various conditions, including neuropathic pain and diabetic neuropathy.

Awards 🏆

Dr. Goel has been honored with the Best Teacher Excellence Award by Dr. A.P.J. Abdul Kalam University, Lucknow. She has also received a travel grant from the same institution and holds multiple patents for her innovative contributions in pharmaceutical sciences.

Publications Top Notes📚

Potential protective effects of Acacia nilotica (L.) against gentamicin-induced nephrotoxicity, Drug and Chemical Toxicology, 2024. (Accepted)

Immunotherapies: A Treasure Trove of Alzheimer’s Disease, Curr Pharm Biotechnol, 2024. (Accepted)

Formulation of Phytosomes Containing Rubia cordifolia Extract for Neuropathic Pain, ACS Omega, 2024. (Co-Author)

Nanophytosomal Gel of Heydotis corymbosa (L.) Extract against Psoriasis, Pharmaceuticals, 2024. (Co-Author)

Rubia cordifolia L. Attenuates Diabetic Neuropathy by Inhibiting Apoptosis, Pharmaceuticals, 2023. (Corresponding Author)

Dr. Radha Goel is a strong candidate for the Research for Best Researcher Award due to her extensive experience, significant research contributions, and notable achievements in patents and publications. Her work demonstrates a profound impact on pharmacological research and innovation. Addressing the areas for improvement, such as increasing the impact of her research and expanding collaborative efforts, could further enhance her profile. Overall, her achievements and contributions make her a deserving candidate for this award